SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001683168-20-003389
Filing Date
2020-10-07
Accepted
2020-10-07 17:00:38
Documents
1

Document Format Files

Seq Description Document Type Size
1 FORM 424B3 cns_424b3.htm 424B3 215511
  Complete submission text file 0001683168-20-003389.txt   216505
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185 X701
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

IRS No.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-249068 | Film No.: 201229577
SIC: 2834 Pharmaceutical Preparations